OncoCyte Corporation Profile Avatar - Palmy Investing

OncoCyte Corporation

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test fo…

Biotechnology
US, Irvine [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

OncoCyte Corporation has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

OncoCyte Corporation can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of OncoCyte Corporation.

End of OCX's Analysis
CIK: 1642380 CUSIP: 68235C107 ISIN: US68235C2061 LEI: - UEI: -
Secondary Listings
OCX has no secondary listings inside our databases.